SGX Halts Clinical Trial
SGX Pharmaceuticals Inc. (SGXP) halted a clinical trial for its leukemia drug Troxatyl sending the stock price plunging $1.89 to close at $2.71.
posted by FC Market News at 10:52 AM
Tuesday, August 29, 2006
Previous Posts
- Positive Results For ViroPharma Drug Trial
- Delek Wants Stake In Phoenix Holdings
- Woodside Makes Offer For Energy Partners
- Gtech Replaced By Charming Shoppes
- Epix Appeal Denied
- Corel Buys InterVideo
- Kinder Morgan Acquired
- Newfield Upgraded
- Centene's Medicaid Contract Ends
- Hoku To Build Plant
0 Comments:
Post a Comment
<< Home